Eliana Trink

The Akt-specific inhibitor MK2206 selectively inhibits thyroid cancer cells harboring mutations that can activate the PI3K/Akt pathway.

G. Ning, M. Xing, Dingxie Liu, 2011, The Journal of clinical endocrinology and metabolism.

The Akt-specific inhibitor MK2206 selectively inhibits thyroid cancer cells harboring mutations that can activate the PI3K/Akt pathway.

G. Ning, M. Xing, Dingxie Liu, 2011, The Journal of clinical endocrinology and metabolism.

Thermal latency studies in opiate-treated mice

Eliana Trink, B. Tyler, M. Guarnieri, 2014, Journal of pharmacy & bioallied sciences.